Diagnosing Adverse Drug Reactions Registry — DART

Genetics of Drug Metabolism Clinical Trial

Official title:
DART Registry: Diagnosing Adverse Drug Reactions Registry

Status Active, not recruiting

Clinical Trial Summary

This multicenter Registry is to assess whether the use of pharmacogenomic data results in a meaningful change in a subject's drug or dose regimen. In addition, the Registry will evaluate the relationship between adverse drug reactions (ADR) and genotype and assess resource utilization (emergency department visits and hospitalizations) associated with ADR.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

Drug-Related Side Effects and Adverse Reactions
Genetics of Drug Metabolism

Clinical Trial Details

NCT number	NCT01970709
Study type	Observational [Patient Registry]
Source	Renaissance RX
Contact
Status	Active, not recruiting
Phase	N/A
Start date	November 2013

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02081872` - Utility of PharmacoGenomics for Reducing Adverse Drug Effects	N/A
	Recruiting	`NCT02095769` - Pharmacogenomic Testing Of the Elderly To Reduce Morbidity	N/A